| Literature DB >> 21686150 |
Eduardo Cemeli1, Diana Anderson.
Abstract
Past research has demonstrated that oestrogenic compounds produce strand breaks in the DNA of sperm and lymphocytes via reactive oxygen species (ROS). In the current investigation, sperm and lymphocytes were treated in vitro with oestrogenic compounds (diethylstilboestrol, progesterone, 17β-oestradiol, noradrenaline and triiodotyronine) and several aspects of DNA damage were investigated. Firstly, mediation of DNA damage by lipid peroxidation was investigated in the presence of BHA (a lipid peroxidation blocker). BHA reduced the DNA damage generated by 17β-oestradiol and diethylstilboestrol in a statistically significant manner. No effects were observed for sperm. Secondly, the presence of oxidized bases employing FPG and EndoIII were detected for lymphocytes and sperm in the negative control and after 24 h recovery in lymphocytes but not immediately after treatment for both cell types. The successful detection of oxidized bases in the negative control (untreated) of sperm provides an opportunity for its application in biomonitoring studies. DNA repair at 24 h after exposure was also studied. A nearly complete recovery to negative control levels was shown in lymphocytes 24 h recovery after oestrogenic exposure and this was statistically significant in all cases. Rapid rejoining of DNA, in a matter of hours, is a characteristic of DNA damaged by ROS.Entities:
Keywords: ROS; comet assay; lipid peroxidation; lymphocytes; oestrogens; sperm
Mesh:
Substances:
Year: 2011 PMID: 21686150 PMCID: PMC3116156 DOI: 10.3390/ijms12052783
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1.The Olive Tail Moment values for lymphocytes (a) and sperm (b) treated with oestrogenic compounds or H2O2 for 30 min at 37 °C in the presence and absence of BHA (500 μM). The figures express the mean of the values obtained from 7 independent experiments (n = 7 different donors) in (a) and 5 independent experiments (n = 5 different donors) in (b). For (a) the average age was 27.57 ± 2.41 and for (b) the average age was 30.80 ± 2.35. Normality of the data was evaluated with the Shapiro-Wilks test. Data were normally distributed. The Student’s T-test was applied. For statistical interpretation of the data, treatment in the absence of BHA was compared to treatment with the same compound with its presence. The levels of significance are included: n.s. not significant; *p ≤ 0.05; **p ≤ 0.01 and ***p ≤ 0.001.
Treatment of lymphocytes and sperm with 5 oestrogenic compounds, H2O2 and the negative control with and without the presence of FPG (1:3000) and Endo III (1:3000). The table expresses the mean of the values obtained from 7 independent experiments (n = 7 different donors) for lymphocytes and 5 independent experiments (n = 5 different donors) for sperm. For lymphocytes the average age was 27.57 ± 2.41. For sperm the average age was 30.8 ± 2.35. The data were evaluated for normality with the Shapiro-Wilks test. The data were normally distributed. ANOVA with Dunnet’s post-hoc was applied. For statistical interpretation of data, treatments with FPG or EndoIII were compared to the corresponding control.
| Control | Buffer | 3.65 ± 0.28 | 1.89 ± 0.32 | 2.94 ± 0.24 |
| FPG | 6.29 ± 0.85 ( | 2.34 ± 0.72 (n.s.) | 3.96 ± 0.34 ( | |
| EndoIII | 6.36 ± 0.55 ( | 2.08 ± 1.65 (n.s.) | 4.12 ± 0.36 ( | |
| H2O2 | 50 μM | 17.13 ± 1.22 | 5.44 ± 1.36 | 4.98 ± 0.40 |
| FPG | 16.72 ± 1.21 (n.s.) | 6.51 ± 1.71 (n.s.) | 4.91 ± 0.52 (n.s.) | |
| EndoIII | 18.45 ± 1.16 (n.s.) | 5.94 ± 1.80 (n.s.) | 5.03 ± 0.47 (n.s.) | |
| 17 β-oestradiol | 100 μM | 8.01 ± 1.72 | 2.51 ± 0.70 | 5.52 ± 0.67 |
| FPG | 8.89 ± 1.43 (n.s.) | 2.97 ± 0.73 (n.s.) | 6.24 ± 1.07 (n.s.) | |
| EndoIII | 9.04 ±1.57 (n.s.) | 3.01 ±0.65 (n.s.) | 3.65 ± 0.50 ( | |
| Progesterone | 100 μM | 7.81 ± 1.34 | 2.76 ± 0.64 | 6.35 ± 0.57 |
| FPG | 7.82 ± 1.23 (n.s.) | 2.89 ± 0.63 (n.s.) | 5.44 ± 0.65 (n.s.) | |
| EndoIII | 7.04 ±1.09 (n.s.) | 2.94 ±0.53 (n.s.) | 5.82 ± 0.92 (n.s.) | |
| DES | 100 μM | 22.62 ± 3.73 | 3.03 ± 0.86 | 6.55 ± 0.81 |
| FPG | 24.90 ± 4.22 (n.s.) | 4.80 ± 1.30 (n.s.) | 5.48 ± 0.56 (n.s.) | |
| EndoIII | 24.01 ± 3.24 (n.s.) | 3.28 ± 1.56 (n.s.) | 4.92 ± 0.75 (n.s.) | |
| T3 | 46.9 μM | 6.63 ± 1.03 | 2.02 ± 0.29 | 4.11 ± 1.12 |
| FPG | 6.99 ± 1.31 (n.s.) | 2.53 ± 0.33 (n.s.) | 4.12 ± 0.43 (n.s.) | |
| EndoIII | 6.09 ± 0.94 (n.s.) | 2.28 ± 0.26 (n.s.) | 4.45 ± 0.89 (n.s.) | |
| Noradrenaline | 100 μM | 13.08 ± 2.91 | 2.72 ± 0.75 | 3.39 ± 0.70 |
| FPG | 13.04 ± 1.30 (n.s.) | 3.93 ± 1.23 (n.s.) | 3.25 ± 0.77 (n.s.) | |
| EndoIII | 13.50 ± 1.14 (n.s.) | 2.78 ± 0.57 (n.s.) | 2.79 ± 0.34 (n.s.) | |
The levels of significance are included: n.s. not significant;
p ≤ 0.05;
p ≤ 0.01 and
p ≤ 0.001. H2O2: hydrogen peroxide; DES: diethylstilboestrol; T3: triiodo-L-thyronine.
Figure 2.The Olive Tail Moment values for fresh lymphocytes treated with oestrogenic compounds or H2O2 for 120 min and after 24 h repair in fresh medium. The mean of the values obtained from 7 independent experiments are shown (n = 7 different donors). Average age is 27.57 ± 2.41. Normality of the data was evaluated with the Shapiro-Wilks test. Data were normally distributed. The Student’s T-test was applied. For statistical interpretation of the data, no repair versus repair for each of the oestrogenic compounds was compared. The levels of significance are included: n.s. not significant; *p ≤ 0.05; **p ≤ 0.01 and ***p ≤ 0.001.